Advisory Committee To Review Disease Modifying Claim For Teva's Parkinson's Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
In large early Parkinson's trial, one dose worked but another did not. Review will show how results from innovative trial will be received by FDA.